MLICM
EXPO icon

Metropolitan Life Insurance Company (MetLife)’s Exponent EXPO Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio EXPO Stock Details EXPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,660
Closed -$220K – 726
2024
Q1 		$220K Sell
2,660
-255
-9% -$21.1K 0.01% 678
2023
Q4 		$257K Hold
2,915
– – 0.01% 629
2023
Q3 		$250K Buy
2,915
+129
+5% +$11.7K 0.01% 593
2023
Q2 		$260K Buy
2,786
+40
+1% +$3.76K 0.01% 583
2023
Q1 		$274K Sell
2,746
-361
-12% -$36.7K 0.01% 571
2022
Q4 		$308K Hold
3,107
– – 0.01% 561
2022
Q3 		$272K Hold
3,107
– – 0.01% 583
2022
Q2 		$284K Sell
3,107
-136
-4% -$12.8K 0.01% 589
2022
Q1 		$350K Sell
3,243
-9,955
-75% -$960K 0.01% 604
2021
Q4 		$1.54M Sell
13,198
-363
-3% -$42.7K 0.02% 678
2021
Q3 		$1.53M Sell
13,561
-857
-6% -$92.4K 0.02% 663
2021
Q2 		$1.29M Buy
14,418
+682
+5% +$63.9K 0.02% 812
2021
Q1 		$1.34M Sell
13,736
-502
-4% -$47.1K 0.02% 756
2020
Q4 		$1.28M Sell
14,238
-699
-5% -$55.7K 0.02% 727
2020
Q3 		$1.08M Sell
14,937
-1,029
-6% -$81.8K 0.02% 697
2020
Q2 		$1.29M Buy
15,966
+586
+4% +$42.2K 0.02% 594
2020
Q1 		$1.11M Sell
15,380
-603
-4% -$43.8K 0.02% 628
2019
Q4 		$1.1M Sell
15,983
-272
-2% -$18K 0.02% 837
2019
Q3 		$1.14M Buy
16,255
+52
+0.3% +$3.51K 0.02% 792
2019
Q2 		$949K Hold
16,203
– – 0.02% 928
2019
Q1 		$935K Sell
16,203
-336
-2% -$18.1K 0.02% 917
2018
Q4 		$839K Buy
16,539
+289
+2% +$14.5K 0.02% 900
2018
Q3 		$871K Hold
16,250
– – 0.01% 1008
2018
Q2 		$785K Buy
16,250
+230
+1% +$10.5K 0.01% 1046
2018
Q1 		$630K Buy
16,020
+58
+0.4% +$2.19K 0.01% 1126
2017
Q4 		$567K Sell
15,962
-19,798
-55% -$727K 0.01% 1208
2017
Q3 		$1.32M Hold
35,760
– – 0.01% 1108
2017
Q2 		$1.04M Hold
35,760
– – 0.01% 1229
2017
Q1 		$1.06M Hold
35,760
– – 0.01% 1198
2016
Q4 		$1.08M Sell
35,760
-930
-3% -$27K 0.01% 1257
2016
Q3 		$937K Hold
36,690
– – 0.01% 1314
2016
Q2 		$1.07M Hold
36,690
– – 0.01% 1218
2016
Q1 		$936K Buy
36,690
+546
+2% +$13.2K 0.01% 1213
2015
Q4 		$903K Buy
36,144
+2,142
+6% +$54.4K 0.01% 1237
2015
Q3 		$758K Sell
34,002
-5,608
-14% -$123K 0.01% 1346
2015
Q2 		$887K Sell
39,610
-2,846
-7% -$62.5K 0.01% 1366
2015
Q1 		$944K Hold
42,456
– – 0.01% 1222
2014
Q4 		$876K Buy
42,456
+320
+0.8% +$6.21K 0.01% 1414
2014
Q3 		$747K Sell
42,136
-516
-1% -$9.48K 0.01% 1461
2014
Q2 		$790K Hold
42,652
– – 0.01% 1516
2014
Q1 		$800K Hold
42,652
– – 0.01% 1506
2013
Q4 		$826K Buy
42,652
+3,040
+8% +$57.4K 0.01% 1467
2013
Q3 		$711K Sell
39,612
-4,756
-11% -$79.3K 0.01% 1517
2013
Q2 		$656K Buy
+44,368
New +$609K 0.01% 1510

Other funds holding EXPO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s EXPO Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Exponent (EXPO) in Q2 2024, closing a stake of 2,660 shares — an estimated $220K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in EXPO in Q2 2013 and held it in 44 quarters. The position peaked at $1.54M in Q4 2021. 354 funds tracked by Wall St. Rank hold EXPO as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Exponent position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,660 Exponent shares in Q2 2024, an estimated $220K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Exponent in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Exponent position peaked at $1.54M in Q4 2021.
  • 354 funds tracked by Wall St. Rank held Exponent as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.